Biosimilar Manufacturing solution center

1. Building Trust In AI For Computerized System Validation 9/4/2026

   Using AI for CSV might feel like the students are grading their own papers. One consultant explains why it's not the same, namely, there are no subjective judgment calls.

2. Controls For Retrieval-Augmented Generation In GxP 9/1/2026

   Validation teams deal with inherent variability all the time. The same principles for GMP — think visual inspection — can apply to probabilistic AI systems.

3. Don't Intensify Blindly: Preventing Fouling And Restoring Performance With Targeted Cleaning Of Protein A Resins 8/27/2026

   Protein A chromatography intensification can increase productivity, but it may also affect process robustness. Explore key tradeoffs, operational challenges, and practical considerations.

4. Optimize Process Performance And Maximize HCP Removal 8/27/2026

   Compare filtration strategies and explore how filter selection affects host cell protein removal, processing efficiency, and the balance between impurity clearance and filtration performance.

5. Implementing And Optimizing Your eQMS 8/25/2026

   This article addresses everything that follows the signed contract for an eQMS: how a system is configured, validated, adopted, and maintained.

6. Chromatography Equipment Maintenance In An Era Of Acceleration 8/19/2026

   As chromatography systems become more sophisticated, maintenance directly influences uptime. Learn why coordinated maintenance strategies are essential for supporting complex analytical work.

7. Why You Need Spare Parts On Hand For Pharma And Lab Equipment 8/19/2026

   Advanced spare parts planning can reduce downtime. Learn why precise component specifications matter and how seemingly identical parts can differ significantly in quality, performance, and failure risk.

8. Benefits Of Preventive Maintenance For Pharma Manufacturing 8/19/2026

   Preventive maintenance helps reduce equipment failures. Learn why regular service schedules are becoming even more important as biopharmaceutical production shifts toward continuous processing.

9. A Much-Improved Approach For Understanding And Managing Safety Risks 8/18/2026

   Learn how causal mechanism and effect analysis (CMEA) and its principles can be used to develop and maintain safer working environments in the pharma/biotech and medical device industries.

10. Bioprocessing Observability: Why Real-Time Monitoring Matters 8/17/2026

    Bioprocessing produces more data than ever, but many organizations still struggle to turn it into action. Better integration can support faster decisions and more predictable performance.